Online ECHO Clinic | April 16, 2020

Presentation Title: Buprenorphine Prescribing in a Pandemic

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews best practices for buprenorphine
prescribing during COVID‐19 and the changing regulations around prescribing. She also shares a sample model for increasing access to buprenorphine.


Video

Presenter Bios

Jessica Gregg, MD, PhD, is an Associate Professor of Medicine at Oregon Health and Science University. She received her undergraduate degree from Stanford University, her medical degree from the University of New Mexico, and her doctorate in medical anthropology from Emory University. She is board certified in internal medicine and addiction medicine. At OHSU, Dr. Gregg serves as the Director of the university’s addiction medicine ECHO clinics, as Associate Program Director for OHSU’s addiction medicine fellowship, and as Medical Director of the OHSU HRBR clinic, which provides low-barrier MAT to vulnerable adults. She also provides clinical care on IMPACT, OHSU’s inpatient addiction medical consult service.

Jennifer Hartley, MD, PhD, is a Family Medicine Practitioner at Portland Urgent Care.

Presentation Slides

Buprenorphine Prescribing in a Pandemic